The biological effects of lung-derived mediators on the liver

Experimental Lung Research

Volumn 37, Issue 7, 2011, Pages 419-426

  Rocca, Nicole A ^a   Walker, Melissa G ^a   McCaig, Lynda A ^a   Yao, Li Juan ^a   Potter, Richard F ^a   Veldhuizen, Ruud A W ^a   Lewis, James F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Inflammation; Intravital microscopy; Isolated perfused lung; Liver; Lung injury; Multiple organ failure

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; CREATININE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LACTIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL DEATH; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; ESCHERICHIA COLI; IN VIVO STUDY; LEUKOCYTE COUNT; LIVER PROTECTION; LUNG LAVAGE; LUNG PERFUSION; MALE; MICROSCOPY; MOUSE; NONHUMAN; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LIVER; LUNG; MICE; MICROSCOPY, VIDEO; PERFUSION; RESPIRATION, ARTIFICIAL;

EID: 80051718196     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2011.583712     Document Type: Article

References (24)

1. Bernard GR, Artigas A, Brigham KL, et al.: The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-824.
2. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
3. Ware LB: Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27:337-349.
4. Meduri GU, Kohler G, Headley S, et al.: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108: 1303-1314.
5. Greene KE, Wright JR, Steinberg KP, et al.: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999;160:1843-1850.
6. Veldhuizen RA, McCaig LA, Akino T, et al.: Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1867-1871.
7. Phua J, Badia JR, Adhikari NK, et al.: Has mortality from acute respiratory distress syndrome decreased over time? a systemic review. Am J Respir Crit Care Med. 2009;180:1158-1159
8. Ranieri VM, Giunta F, Suter PM, et al.:Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284:43-44.
9. Slutsky AS, Ranieri VM: Mechanical ventilation: Lessons from the ARDSNet trial. Respir Res. 2000;1:73-77.
10. Markovic N, McCaig LA, Stephen J, et al.: Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1066-1076.
11. Schwartz DB, Bone RC, Balk RA, et al.: Hepatic dysfunction in the adult respiratory distress syndrome. Chest. 1989;95:871-875.
12. Stamme C, Brasch F, von Bethmann A, et al.: Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. Pulm Pharmacol Ther. 2002;15:455-461.
13. Walker MG, Tessolini JM, McCaig L, et al.: Elevated endogenous surfactant reduces inflammation in an acute lung injury model. Exp Lung Res. 2009;35:591-604.
14. Ott MC, Scott JR, Bihari A, et al.: Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion. FASEB J. 2005;19:106-108.
15. Ranieri VM, Suter PM, Tortorella C, et al.: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA. 1999;282:54-61.
16. Brower RG, Matthay MA, Wheeler AP: The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.
17. Parsons PE, Eisner MD, Thompson BT, et al.: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit CareMed. 2005;33:1-6.
18. Dreyfuss D, Saumon G: Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med. 1998;157:294-323.
19. Tremblay L, Valenza F, Ribeiro SP, et al.: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest. 1997;99:944-952.
20. Imai Y, Parodo J, Kajikawa O, et al.: Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289:2104-2112.
21. Sprung CL, Caralis PV, Marcial EH, et al.: The effects of highdose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984;311:1137-1143.
22. Luce JM, Montgomery AB, Marks JD, et al.: Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62-68.
23. Bernard GR, Luce JM, Sprung CL, et al.: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565-1570.
24. St John RC, Dorinsky PM: Immunologic therapy for ARDS, septic shock, and multiple-organ failure. Chest. 1993;103: 932-943.